Bind Biosciences recently closed a $16 million Series B funding round, with investors including Polaris Venture Partners, Flagship Ventures, ARCH Ventures, and NanoDimension. Bind was founded in 2006 by Robert...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)